COMPOSITIONS AND METHODS FOR JOINING NON-CONJOINED LUMENS

• US 20090187199A1
• Filed: 12/19/2008
• Published: 07/23/2009
• Est. Priority Date: 06/21/2006
• Status: Active Grant

• Current Assignee: Board of Trustees of the Leland Stanford Junior University (Stanford Management Co.)
• Original Assignee: Board of Trustees of the Leland Stanford Junior University (Stanford Management Co.)
• Inventors: Mandrusov, Evgenia, Fuller, Gerald G., Rajadas, Jayakumar, Longaker, Michael T., Gurtner, Geoffrey C., Rappleye, C. Travis, Saul, Gordon
• Granted Patent: US 8,197,499 B2
• Time in Patent Office: Days
• US Class Current: 606/153
• CPC Class Codes: A61B 17/00491 Surgical glue applicators surgical adhesives A61L24/00; two-component delivery syringes A61M5/19
• CPC Class Codes: A61B 17/04 for suturing wounds; Holders or packages for needles or suture materials suture materials A61L17/00
• CPC Class Codes: A61B 17/11 for performing anastomosis; Buttons for anastomosis
• CPC Class Codes: A61B 17/122 Clamps or clips , e.g. for the umbilical cord for the vas deferens A61F6/206
• CPC Class Codes: A61B 17/1227 Spring clips
• CPC Class Codes: A61B 2017/1103 Approximator
• CPC Class Codes: A61B 2017/1107 for blood vessels

Abstract

Disclosed are compositions, methods, and kits for joining together non-conjoined lumens in a patient'"'"'s body including vascular lumens. More particularly, in various aspects, this invention provides compositions, methods, and kits for joining such non-conjoined lumens, including small lumens typically requiring microsurgical technique.

Claims

1. A method for joining at least two non-conjoined lumens in a patient, wherein at least one of the lumens has a clamp to arrest the flow of the fluid therein, which method comprises:

(a) providing a biocompatible solid mass at least in a distal portion of the lumen having the clamp;

(b) aligning the lumens;

(c) closing the aligned lumens to form a conduit;

(d) inducing a phase change of the biocompatible solid mass from a solid to a flowable liquid;

(e) confirming substantial completion of the phase change; and

(f) removing the clamp thereby establishing flow through the conduit.

2. The method of claim 1, wherein the biocompatible solid mass is placed in the distal portion of each lumen to be joined.

3. The method of claim 1, wherein the biocompatible solid mass is placed in the distal portion of a first lumen in a manner in which the biocompatible solid mass protrudes from the distal portion such that this protrusion can be used as a male-mating functionality with the distal portion of the second lumen which acts as a female-mating functionality.

4. The method of claim 1, wherein the biocompatible solid mass is a sol-gel composition, a wax or a thixotropic agent.

5. The method of claim 1, wherein the phase change of the biocompatible solid mass comprises melting, phase change triggered by a stimulus, change in viscosity, or combinations thereof.

6. The method of claim 1, which method comprises:

(a) providing a biocompatible phase-reversible sol-gel composition in a gel phase in at least the distal portion of at least the lumen having the clamp;

(b) aligning the lumens;

(c) closing the aligned lumens to form a conduit;

(d) inducing a phase transition of the sol-gel wherein the sol-gel changes from the gel phase to a liquid phase;

(e) confirming substantial completion of the phase transition; and

(f) removing the clamp(s) thereby establishing flow through the conduit and removing the sol-gel composition.

7. The method of claim 6, wherein step (a) comprises:

(a1) placing the phase-reversible sol-gel in a gel phase inside at least a portion of the distal end of at least one of the lumens in a manner which imparts structural integrity to said portion of the lumen.

8. The method of claim 6, wherein step (a) comprises:

(a2) placing the phase-reversible sol-gel in a liquid phase inside at least a portion of the distal end of at least one of the lumens; and

(a3) inducing a phase transition change in the phase-reversible sol-gel in the lumen wherein the liquid phase changes to a gel phase which imparts structural integrity to said portion of the lumen.

15. The method of any one of claims 1, 6 and 11, further comprising flushing the distal portion of the clamped lumen with a biocompatible liquid prior to step (a).

33. The method of claim 1, 6, or 9, wherein joining of the lumens comprises suturing, applying a biocompatible adhesive, applying laser, electrocautery or combinations thereof.

35. The method of claim 33, wherein joining of the lumens comprises using a biocompatible adhesive.

37. The method of claim 33, wherein joining of the lumen comprises a combination of suturing and applying a biocompatible adhesive.

38. The method of claim 33, wherein the biocompatible adhesive is selected from among a cyanoacrylate-based adhesive, a fibrin-based adhesive, a polyurethane-based adhesive, a latex glue, a biologics glue, a polyethylene glycol-based glue, and a polyisocyanate-based adhesive.

39. The method of any one of claims 1, 9, and 16, wherein the lumens are each independently selected from the group consisting of a vessel of the cardiovascular system of the patient human, an arteriovenous graft and an arteriovenous shunt.

40. A method for imaging the joinder of at least two non-conjoined lumens using a method of any one of claims 1, 9, and 16.

41. A method for visualizing guidance of the joinder of at least two non-conjoined lumens using a method of any one of claims 1, 9, and 16.

42. A method for evaluating the effectiveness of a method for joining at least two non-conjoined lumens in a patient using a method of any one of claims 1, 9, and 16.

9. A method for joining at least two non-conjoined lumens in a patient, which method comprises:

(a) approximating the lumens in a connecting position;

(b) providing a biocompatible phase-reversible sol-gel composition in a gel phase in the distal portion of both lumens;

(c) closing the lumens to form a conduit;

(d) inducing a phase transition of the sol-gel wherein the sol-gel changes from the gel phase to a liquid phase; and

(e) establishing flow through the conduit.

10. The method of claim 9, further comprises a step before step (a), which step comprises arresting the flow of body fluid in the lumens.

11. The method of claim 10, wherein the arresting the flow of body fluid in the lumen comprises clamping at least one of the lumens.

12. The method of claim 10, wherein the arresting the flow of body fluid in the lumen comprises applying a pressure on at least one of the lumens.

13. The method of claim 11, wherein step (e) comprises (e1) observing the conduit to confirm substantial completion of the phase transition, and (e2) removing the clamps thereby establishing flow through the conduit and removing the sol-gel composition.

14. The method of claim 9, wherein the approximating the lumens in a connecting position comprises partially suturing the lumens.

16. A method for joining at least two non-conjoined lumens in a patient, wherein at least one of the lumens is clamped to arrest the flow of body fluid therein, which method comprises:

flushing the distal portion of the clamped lumen with a biocompatible liquid;

approximating the lumens in a connecting position, which approximating comprises partially suturing the lumens;

providing a biocompatible phase-reversible sol-gel composition in a gel phase in the distal portion of both lumens;

closing the lumens to form a conduit with a biocompatible adhesive;

inducing a phase transition of the sol-gel wherein the sol-gel changes from the gel phase to a liquid phase;

confirming substantial completion of the phase transition; and

removing the clamps thereby establishing flow through the conduit.

17. The method of any one of claims 6, 9 and 16, wherein the phase-transition of the sol-gel composition is triggered by a stimulus selected from a change in temperature, a change in pH, a change in ionic strength, a change in pressure, a change in electric field, a change in magnetic field, a change in electron magnetic radiation, a change in light or ultraviolet light, a change in concentration, a change in osmolarity, and combinations thereof.

18. The method of any one of claims 6, 9 and 16, wherein the sol-gel composition has an elastic modulus of at least 100 Pascals when in the gel phase.

19. The method of claim 16, wherein the sol-gel composition has an elastic modulus of at least 8,000 Pascals when in the gel phase.

20. The method of any one of claims 6, 9 and 16, wherein the sol-gel composition is a thermoreversible sol-gel having a transition temperature of from about 0°

C. to about 45°

C.

25. The method of claim 20, wherein the sol-gel is maintained in the gel phase by applying a heat source and changed from the solid phase to the liquid phase by removing the heat source.

26. The method of claim 20, wherein the sol-gel is changed from the solid phase to the liquid phase by cooling the joined lumens to a temperature that is below the transition temperature of the sol-gel composition.

28. The method of claim 20, wherein the thermoreversible sol-gel comprises an aqueous solvent and a polymer selected from the group consisting of poloxamer 118, poloxamer 188, poloxamer 338, poloxamer 407, Tetronic®

1107 and Tetronic®

1307, or a mixture thereof.

29. The method of claim 28, wherein the polymer is present in an amount of about 5% to about 35% by weight.

30. The method of any one of claims 6, 9 and 16, wherein the phase-transition of the sol-gel composition is triggered by a stimulus which comprises a change in ionic strength.

21-24. -24. (canceled)

27. (canceled)

31-32. -32. (canceled)

34. (canceled)

36. (canceled)

43-49. -49. (canceled)